Juan Wisnivesky
Pulmonary Disease · New York, NYNPI 1982629416
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Sanofi accounts for 72.1% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $15,940 and has fallen 80.2% since, to $3,162 in 2024. Among pulmonary disease clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 34 payments — averaging $1216.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$30K
- GSK$8K
- Biontech SE$3K
- Sanofi-aventis U.S. LLC$851
Across 27 payments — averaging $132,562 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$3M
- Insmed, Inc.$606K
What the payments were for
- Consulting fees$22,91555%
- Speaking & faculty fees$12,69631%
- Travel & lodging$4,66611%
- Food & beverage$1,0873%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 20 | $29,829 |
| GSK | 11 | $7,521 |
| Biontech SE | 1 | $3,162 |
| Sanofi-aventis U.S. LLC | 2 | $851 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$41,363 in reported general payments places this provider in the 90th percentile of 1,115 pulmonary disease providers in New York.
Other pulmonary disease in New York
- Charles PowellNew York$654K
- Bisher AkilNew York$480K
- Sonali SethiNew York$388K
- Johnathan RaskinNew York$338K
- Monica KraftNew York$247K
- Jamie BessichNew York$226K
- Ronald CrystalNew York$213K
- Michael NiedermanNew York$176K
- Wilfredo TalaveraNew York$145K
- Josanna Rodriguez-LopezNew York$128K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.